Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
- PMID: 13678865
- DOI: 10.1016/S0140-6736(03)14295-X
Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
Comment in
-
The EUROPA trial.Lancet. 2003 Dec 6;362(9399):1935; author reply 1936-7. doi: 10.1016/S0140-6736(03)14970-7. Lancet. 2003. PMID: 14667758 No abstract available.
Comment on
-
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).Lancet. 2003 Sep 6;362(9386):782-8. doi: 10.1016/s0140-6736(03)14286-9. Lancet. 2003. PMID: 13678872 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources